Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Linezolid-induced peripheral neuropathy in a patient with multidrug-resistant pulmonary tuberculosis: a case report and comprehensive literature review.

Neurologia croatica : glasilo Udruzenja neurologa Jugoslavije = official journal of Yugoslav Neurological Association·2026
Same author

Application of a clinical scale for predicting Aβ-positivity in a multicentre Canadian dementia cohort: A necessity in the era of amyloid targeting treatment.

Journal of the neurological sciences·2026
Same author

Selective molecular and network architecture features underlie brain cortical atrophy in dementia with Lewy bodies.

Journal of biomedical science·2026
Same author

Examining the effects of alcohol use on verbal memory processes in older adults with mild cognitive impairment.

Journal of Alzheimer's disease : JAD·2026
Same author

Deconstructing bilingualism and its sociocultural determinants in cognitive aging and Alzheimer's disease and related dementias.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Reference data and clustering of lifestyle-based dementia risk factor scales among older Canadian adults.

Experimental gerontology·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Bruna Seixas Lima1, Pedro Rosa-Neto2, Durjoy Lahiri3

  • 1Baycrest Academy for Research and Education, Toronto, ON, Canada.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

血清质纤维酸 (GFAP) 水平是神经炎症的标志物,随着年龄和认知障碍的增加,特别是在阿尔茨海默病 (AD) 和血管痴呆症 (VaD) 中. 周围炎症和BMI与GFAP水平相反相关.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经学 神经学
  • 神经炎症研究 神经炎症研究
  • 生物标志物发现发现

背景情况:

  • 神经炎症是阿尔茨海默病 (AD) 和相关痴呆症的关键因素.
  • 质纤维酸蛋白 (GFAP) 是一种反映神经炎症的天体细胞衍生生物标志物.
  • 这项研究检查了与认知状态和临床特征相关的血清GFAP水平.

研究的目的:

  • 在患有阿尔茨海默氏症,血管痴呆症 (VaD),轻度认知障碍 (MCI),血管MCI (V-MCI) 和认知无障碍 (CU) 的个人中调查血清GFAP水平.
  • 探索GFAP水平与临床特征之间的关系,包括年龄,性别和血管疾病标志物.
  • 了解神经炎症 (GFAP) 和外周炎症 (CRP,IL-6) 与体重指数 (BMI) 之间的关联.

主要方法:

  • 血清GFAP水平测量了60名AD,65名VaD,179名MCI,122名V-MCI和88名CU参与者.
  • 参与者被分为低GFAP,中等GFAP和高GFAP.
  • 累积链接建模分析了GFAP与人口,临床和炎症变量之间的关联,包括CRP,IL-6,BMI和Fazekas尺度得分.

主要成果:

  • 在GFAP三位体和年龄,AD诊断,VaD诊断,MoCA得分,性别,CRP和BMI之间发现了显著的关联.
  • 较低的GFAP水平与较高的CRP和BMI相关.
  • GFAP水平与营养,睡眠质量,吸烟史,并发症数量或MRI衍生的白质病变 (Fazekas尺度) 不相关.

结论:

  • 血清GFAP水平随着年龄的增长而增加,并且在认知障碍中升高,特别是在AD和VaD中.
  • 周围炎症 (CRP) 和BMI显示与神经炎症 (GFAP) 的反向关系.
  • 在这个队列中,高GFAP与白质病变或血管疾病严重程度没有直接联系.